Expressive Suppression and Negative Affect, Pathways of Emotional Dysregulation in Psoriasis Patients

Abstract

The main goal of this study was to assess the emotion regulation (ER) mechanisms, such as expressive suppression and cognitive reappraisal, in patients with psoriasis, as compared with healthy persons not afflicted by dermatological diseases. Moreover, the study intended to carry on a multidimensional assessment of emotional mechanisms in persons with psoriasis, highlighting the differences between psoriasis patients and healthy participants, in order to identify the specific patterns of emotion dysregulation (ED) in psoriasis. Another goal of the study was to investigate the predictors of ED among different emotional patterns. We presumed that the maladaptive ER mechanisms are higher in psoriasis patients than in the control group and there are specific dysregulation patterns in psoriasis patients as negative emotions tendency. This cross-sectional study was performed on 192 individuals aged between 35 and 75 years (mean age 59). The sample was divided in two groups: the clinical group including 91 patients with a diagnosis of psoriasis vulgaris and the control group including 101 healthy persons. The results of the present study suggest that psoriasis patients more frequently used emotional suppression – a maladaptive ER mechanism – as well as ED patterns – i.e., impulse control difficulties, and nonacceptance of emotional responses. They also displayed trait tendency to a negative emotional response. In fact, in people with psoriasis, the presence of suppression mechanism and negative affect of trait could predict that 35% of patients will show emotional dysregulated patterns, while living with higher levels of ED. The results of our study are important in the clinical practice, helping clinicians to better understand the emotional vulnerability of people that live with psoriatic disease, and to optimize the disease management and patient care in an interdisciplinary approach.

COVID‐19 and psoriasis: Should we fear for patients treated with biologics?

“…In times in which the COVID-19 fear could lead to over psychological distress, people with disease such as psoriasis, may worsen, since they are already striving with a chronic psychologically distressing disease. 30 Stopping immunosuppressive or immunomodulating treatment in psoriasis could lead to reduced response at retreatment due to several reasons, the most important of which is immunogenicity. 3 We can speculate on three strong evidences that were discussed above:…”

Emotions, Alexithymia, and Emotion Regulation in Patients With Psoriasis

“…Compared with controls, patients with psoriasis are characterized by higher use of emotional suppression (Vari et al, 2013;Ciuluvica et al, 2014Ciuluvica et al, , 2019, an emotion regulation strategy considered rather primitive that consists in inhibiting the expression of the ongoing emotional response once it has been generated (Gross and John, 2003). Interestingly, this is the same strategy used by recovered-depressed patients (Ehring et al, 2010).…”

Common Psychological Factors in Chronic Diseases

“…A number of studies have, for instance, already explored the impact of signs and symptoms belonging to the realm of psychopathological disorders on the most common CPDs, with a measure of the subjective perception of well-being and QoL (Megari, 2013). More specifically, alexithymia, anxiety, depression, psychological distress, sleep quality, and emotional dysregulations have been systematically assessed in patients with fibromyalgia, Type 2 diabetes, psoriasis, and osteoporosis (Palagini et al, 2016; Catalano et al, 2018; Martino et al, 2018a,b; Cristina et al, 2019; Kelly et al, 2019; Marchi et al, 2019; Martino M. L. et al, 2019; Settineri et al, 2019a,b). This datum represents the increasing tendency of the scientific community to take an interest in the aforementioned connection between the psychological and physical spheres, hypothesizing a positive correlation between the two, where a higher psychological and QoL malaise correspond to the increasing severity of the pathology.…”